Navigation Links
Cooperatives Can Address Health Care Needs if Properly Defined and Adequate Consumer Protections are Established
Date:6/19/2009

billion in revenues and $74 billion in wages and benefits. They operate in every industry, and range from locally owned to Fortune 500-listed businesses.

For more information about health care cooperatives, visit NCBA's Web site, www.ncba.coop. There's a link to the research's section on health cooperatives on our Web site's home page.

    CONTACT:
    Paul Hazen, President and CEO
    Work: (202) 383.5444
    Cell: (202) 957.9298
    info@ncba.coop

    Mary Griffin, Senior Policy Advisor
    Work: (202) 383.5450
    Cell: (202) 276.7141
    mgriffin@ncba.coop


'/>"/>
SOURCE National Cooperative Business Association
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Provocative New Nonfiction Addresses Spiritual Destiny
2. Government of Canada supports research to help address medical isotope shortage
3. Arizona Governor Jan Brewer Addresses National Conference on Tobacco During Opening Session in Phoenix
4. Actuaries Weigh in on Ways to Address Risk Exposures and Challenges with the U.S. Health Care System
5. U.S. Drug Czar Addresses 2,500 Drug Court Professionals, Voices Strong Support for Expanding Drug Courts Throughout the Nation
6. Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine
7. Answer to President Obamas June 6th Weekly Radio Address
8. Cox Business Addresses Complex Voice Needs of Health Care Organization
9. Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
10. MDS Nordion Urges Government of Canada to Complete MAPLE Project to Address Current Medical Isotope Supply Shortage
11. Air Products CEO to Address Goldman Sachs Basic Materials Conference on 4 June

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire/--NIP,Inc.todayannouncedtheacquisitionof...ingexecutivecompensationandbenefitplanprovidershea...esinLosAngeles,Milwaukee,Boston,ChicagoandAtlanta....ertintheexecutivebenefitsindustry. ,, "Weareexc...gnificantmarketpresence,"statesBillPollock,Chairma...
(Date:11/24/2009)...Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarewill...gHispanic-AmericanseniorsunderstandthebasicsofMedi...eafreeZumba®Goldclass,aLatin-infusedfitnesspr...umba,andtango. ,, UnitedHealthcarewillofferthes...engagedwhenlearningabouttheirhealthcareoptions. T...
(Date:11/24/2009)...ewswire/--TheUnionLaborLifeInsuranceCompany("Union...#174;),()thenation,slargestvisionbenefitsandservic...tounions,uniontrustfunds,unionemployersandtheirmem...servicesincludingcomprehensiveeyeexams,broadselect...ntqualityeyecareis,"statedBruceSmith,NationalSales...
(Date:11/24/2009)... help ward off peripheral artery disease, researc... News) -- Among people aged 75 and older, the herb... attacks, stroke or death, a new study finds. ,...medy might help prevent the leg-circulation proble..., Ginkgo contains nutrients called flavonoids, whi...
(Date:11/24/2009)...t differ greatly between high- and low-volume cent...ealthDay News) -- Do hospitals that conduct the mo...lts for patients? Maybe not. , Prior research h... comes to artery-opening procedures, but a new stu...igh-volume hospitals performing more or less equal...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...tuberculosis drug, currently in the experimental p... drug resistant and latent infections as well. The...// than those used for conventional treatment. ...d spectrum of non-pathogenic microorganisms that e...
...s to be profound links between land-based pollutio...o scientists, physicians, and veterinarians, that .../ According to Paul Sandifer, Chief Scientist ...ues of our unseen impact on the sea, there is moun...
...s come into existence to protect the traditional k...es. Charles McManis, J.D., IP and technology law ...at Washington University in St. Louis has come wit...hey said that existing intellectual property regim...
...Cunnane, a metabolic physiologist at the Universit...d secure shore-based diet that fuelled and provide...they are today. Early hominid brains // underwent ...owth. Our brains weigh roughly twice as much as th...
...titioned for reduction on VAT for condoms, to be r...arrant abolishment of VAT on condoms, the best tha...gly invoked a re-categorization of condoms from a ...m Fins bury, a High Street retailer, who wishes an...
...ty of Jerusalem researchers report that another he...duce cholesterol in blood. As a result it reduces ... has found that heart patients who eat one grapefr... in the reduction of incidence of heart ailments a...
Other Medicine News:Health News:New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment 2Health News:Mystery behind the evolution of the Human brain 2Health News:One fruit that has captured the health benefit sector is Grapefruit! 2
(Date:11/24/2009)...OXThanksgivingDaytelevisionspecialcalled"Kaleidosc...ttheholidaysareatimetobegratefulformanydevelopment...tbattleeachdayassurvivors,caregivers,andadvocates....eiceofcancersurvivorsScottHamiltonandDorothyHamill...rwhowillperform"HopeisAlwaysHere,"asongwrittenbych...
(Date:11/24/2009)...e-FirstCall/--BioSpecificsTechnologiesCorp.(Nasdaq...nclasscollagenase-basedproducts,todayannouncedthat...pcomingPiperJaffray21stAnnualHealthCareConferenceo...ceHotelinNewYork,NY. ,, Alivewebcastofthepresen...estorRelationssectionoftheCompany,swebsiteat www.b...
(Date:11/23/2009)...ooftheChicagoarea,sleadingBoardCertifiedDiagnostic...aging,couplingthelatesttechnologyindigitalmammogra...tytohavethefullrangeofdigitalimagingcompleted,diag...ffice.Drs.AhmedFaragandJoanWerberaredeliveringthis...waitforanappointmentcommonlyfoundinChicago,fromthe...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 1Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 2Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 3New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 1New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 2New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 3Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 1Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 2
...ual Meeting of EASL , , Management to Discuss Stu...Results Call at 5 P.M. EDT Today , , SAN DIEGO, ...ANDS ) today announced that ANA598, the Company,s ...r, demonstrated potent antiviral activity at all d...udy in which patients chronically infected with th...
...d nearly double SVR rate compared to standard of c...hibitor SCH 900518 presented at EASL annual meetin...ugh Corporation (NYSE: SGP ) today reported that...ceprevir, its investigational oral hepatitis C pro... alfa-2b and ribavirin, significantly increased su...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: